HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moses, M. A. Search for Related Content PubMed PubMed Citation Articles by Moses, M. A.

The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors

The Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Key Words. MMPs • TIMPs • Angiogenesis inhibitors • Proteolytic enzymes

Dr. Marsha A. Moses, Laboratory of Surgical Research, Children's Hospital, 320 Longwood Avenue, Boston, MA 02115, USA.

The process of new capillary formation from pre-existing vessels, angiogenesis, is a complex physiological event which is strictly controlled, occurring only very rarely under normal conditions. In contrast, there are a number of serious diseases, among them solid tumor growth, rheumatoid arthritis and several eye diseases, which are characterized by unrestricted new capillary growth and which are described as "angiogenic diseases." One of the key events required for successful angiogenesis is extracellular proteolysis. Increased attention has been focused on the matrix metalloproteinase (MMP) family of enzymes whose activity is a rate-limiting step in extracellular matrix remodeling. This review will present the accumulating body of evidence, from a number of laboratories, which documents the important role of MMP activity in the regulation of angiogenesis. Taken together, these data suggest that one strategy for controlling the deregulated angiogenesis characteristic of these serious angiogenic diseases may be one which is operative at the level of the control of MMP activity.

This article has been cited by other articles:

				K. Naruse, G. E. Lash, B. A. Innes, H. A. Otun, R. F. Searle, S. C. Robson, and J. N. Bulmer Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy Hum. Reprod., December 16, 2008; (2008) den408v1. [Abstract] [Full Text] [PDF]

				J. R. Newman, I. A. Bohannon, W. Zhang, J. B. Skipper, W. E. Grizzle, and E. L. Rosenthal Modulation of Tumor Cell Growth In Vivo by Extracellular Matrix Metalloprotease Inducer Arch Otolaryngol Head Neck Surg, November 1, 2008; 134(11): 1218 - 1224. [Abstract] [Full Text] [PDF]

				R. Adya, B. K. Tan, A. Punn, J. Chen, and H. S. Randeva Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis Cardiovasc Res, May 1, 2008; 78(2): 356 - 365. [Abstract] [Full Text] [PDF]

				N. A. Hasaneen, S. Zucker, R. Z. Lin, G. G. Vaday, R. A. Panettieri, and H. D. Foda Angiogenesis is induced by airway smooth muscle strain Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1059 - L1068. [Abstract] [Full Text] [PDF]

				H Kliem, H Welter, W D Kraetzl, M Steffl, H H D Meyer, D Schams, and B Berisha Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum Reproduction, September 1, 2007; 134(3): 535 - 547. [Abstract] [Full Text] [PDF]

				F. Suhr, K. Brixius, M. de Marees, B. Bolck, H. Kleinoder, S. Achtzehn, W. Bloch, and J. Mester Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans J Appl Physiol, August 1, 2007; 103(2): 474 - 483. [Abstract] [Full Text] [PDF]

				H. Mu, R. Ohashi, S. Yan, H. Chai, H. Yang, P. Lin, Q. Yao, and C. Chen Adipokine resistin promotes in vitro angiogenesis of human endothelial cells Cardiovasc Res, April 1, 2006; 70(1): 146 - 157. [Abstract] [Full Text] [PDF]

				T.-x. Xie, F.-J. Huang, K. D. Aldape, S.-H. Kang, M. Liu, J. E. Gershenwald, K. Xie, R. Sawaya, and S. Huang Activation of Stat3 in Human Melanoma Promotes Brain Metastasis. Cancer Res., March 15, 2006; 66(6): 3188 - 3196. [Abstract] [Full Text] [PDF]

				Y. Zhu, C. Lee, F. Shen, R. Du, W. L. Young, and G.-Y. Yang Angiopoietin-2 Facilitates Vascular Endothelial Growth Factor-Induced Angiogenesis in the Mature Mouse Brain Stroke, July 1, 2005; 36(7): 1533 - 1537. [Abstract] [Full Text] [PDF]

				S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas J. Biol. Chem., June 10, 2005; 280(23): 21882 - 21892. [Abstract] [Full Text] [PDF]

				Y. Shoshani, J. Pe'er, V. Doviner, J. Frucht-Pery, and A. Solomon Increased Expression of Inflammatory Cytokines and Matrix Metalloproteinases in Pseudophakic Corneal Edema Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1940 - 1947. [Abstract] [Full Text] [PDF]

				Y. Tang, M. T. Nakada, P. Kesavan, F. McCabe, H. Millar, P. Rafferty, P. Bugelski, and L. Yan Extracellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases Cancer Res., April 15, 2005; 65(8): 3193 - 3199. [Abstract] [Full Text] [PDF]

				C.-C. Sun, C.-Y. Cheng, C.-S. Chien, J.-H. S. Pang, W.-C. Ku, P. Y.-F. Chen, and C.-M. Yang Role of Matrix Metalloproteinase-9 in Ex Vivo Expansion of Human Limbal Epithelial Cells Cultured on Human Amniotic Membrane Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 808 - 815. [Abstract] [Full Text] [PDF]

				A. Robinet, A. Fahem, J.-H. Cauchard, E. Huet, L. Vincent, S. Lorimier, F. Antonicelli, C. Soria, M. Crepin, W. Hornebeck, et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP J. Cell Sci., January 15, 2005; 118(2): 343 - 356. [Abstract] [Full Text] [PDF]

				E. D. Karagiannis and A. S. Popel A Theoretical Model of Type I Collagen Proteolysis by Matrix Metalloproteinase (MMP) 2 and Membrane Type 1 MMP in the Presence of Tissue Inhibitor of Metalloproteinase 2 J. Biol. Chem., September 10, 2004; 279(37): 39105 - 39114. [Abstract] [Full Text] [PDF]

				E. Van Valckenborgh, P. I. Croucher, H. De Raeve, C. Carron, E. De Leenheer, S. Blacher, L. Devy, A. Noel, E. De Bruyne, K. Asosingh, et al. Multifunctional Role of Matrix Metalloproteinases in Multiple Myeloma: A Study in the 5T2MM Mouse Model Am. J. Pathol., September 1, 2004; 165(3): 869 - 878. [Abstract] [Full Text] [PDF]

				M. Gattorno, A. Gregorio, F. Ferlito, V. Gerloni, A. Parafioriti, E. Felici, E. Sala, C. Gambini, P. Picco, and A. Martini Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis Rheumatology, September 1, 2004; 43(9): 1091 - 1096. [Abstract] [Full Text] [PDF]

				Y. Nakamura, S. Esnault, T. Maeda, E. A. B. Kelly, J. S. Malter, and N. N. Jarjour Ets-1 Regulates TNF-{alpha}-Induced Matrix Metalloproteinase-9 and Tenascin Expression in Primary Bronchial Fibroblasts J. Immunol., February 1, 2004; 172(3): 1945 - 1952. [Abstract] [Full Text] [PDF]

				K. Ohno-Matsui, T. Uetama, T. Yoshida, M. Hayano, T. Itoh, I. Morita, and M. Mochizuki Reduced Retinal Angiogenesis in MMP-2-Deficient Mice Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5370 - 5375. [Abstract] [Full Text] [PDF]

				L. C. Ginns, D. H. Roberts, E. J. Mark, J. L. Brusch, and J. J. Marler Pulmonary Capillary Hemangiomatosis With Atypical Endotheliomatosis: Successful Antiangiogenic Therapy With Doxycycline Chest, November 1, 2003; 124(5): 2017 - 2022. [Abstract] [Full Text] [PDF]

				C. A. Fernandez, C. Butterfield, G. Jackson, and M. A. Moses Structural and Functional Uncoupling of the Enzymatic and Angiogenic Inhibitory Activities of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2): LOOP 6 IS A NOVEL ANGIOGENESIS INHIBITOR J. Biol. Chem., October 17, 2003; 278(42): 40989 - 40995. [Abstract] [Full Text] [PDF]

				G. Rosenblum, S. O. Meroueh, O. Kleifeld, S. Brown, S. P. Singson, R. Fridman, S. Mobashery, and I. Sagi Structural Basis for Potent Slow Binding Inhibition of Human Matrix Metalloproteinase-2 (MMP-2) J. Biol. Chem., July 11, 2003; 278(29): 27009 - 27015. [Abstract] [Full Text] [PDF]

				X. Yan, Y. Lin, D. Yang, Y. Shen, M. Yuan, Z. Zhang, P. Li, H. Xia, L. Li, D. Luo, et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth Blood, July 1, 2003; 102(1): 184 - 191. [Abstract] [Full Text] [PDF]

				I. Rivilis, M. Milkiewicz, P. Boyd, J. Goldstein, M. D. Brown, S. Egginton, F. M. Hansen, O. Hudlicka, and T. L. Haas Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1430 - H1438. [Abstract] [Full Text] [PDF]

				J. Sanceau, D. D. Boyd, M. Seiki, and B. Bauvois Interferons Inhibit Tumor Necrosis Factor-alpha -mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-kappa B J. Biol. Chem., September 13, 2002; 277(38): 35766 - 35775. [Abstract] [Full Text] [PDF]

				B. Zhang, L. Yan, M. A. Moses, and P. C.W. Tsang Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum Biol Reprod, July 1, 2002; 67(1): 99 - 106. [Abstract] [Full Text] [PDF]

				S. Vignola, P. Picco, F. Falcini, F. Sabatini, A. Buoncompagni, and M. Gattorno Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides Rheumatology, June 1, 2002; 41(6): 691 - 696. [Abstract] [Full Text] [PDF]

				M. M. Bernardo, S. Brown, Z.-H. Li, R. Fridman, and S. Mobashery Design, Synthesis, and Characterization of Potent, Slow-binding Inhibitors That Are Selective for Gelatinases J. Biol. Chem., March 22, 2002; 277(13): 11201 - 11207. [Abstract] [Full Text] [PDF]

				T. Matsumoto and L. Claesson-Welsh VEGF Receptor Signal Transduction Sci. Signal., December 11, 2001; 2001(112): re21 - re21. [Abstract] [Full Text] [PDF]

				M. S. Pepper Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1104 - 1117. [Abstract] [Full Text] [PDF]

				L. Yan and M. A. Moses A Case of Tumor Betrayal : Biphasic Effects of TIMP-1 on Burkitt's Lymphoma Am. J. Pathol., April 1, 2001; 158(4): 1185 - 1190. [Full Text] [PDF]

				A. Boulay, R. Masson, M.-P. Chenard, M. El Fahime, L. Cassard, J.-P. Bellocq, C. Sautèes-Fridman, P. Basset, and M.-C. Rio High Cancer Cell Death in Syngeneic Tumors Developed in Host Mice Deficient for the Stromelysin-3 Matrix Metalloproteinase Cancer Res., March 1, 2001; 61(5): 2189 - 2193. [Abstract] [Full Text]

				G. Davis, K. Pintar Allen, R Salazar, and S. Maxwell Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices J. Cell Sci., January 3, 2001; 114(5): 917 - 930. [Abstract] [PDF]

				S. Majka, P. McGuire, S. Colombo, and A. Das The Balance between Proteinases and Inhibitors in a Murine Model of Proliferative Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 210 - 215. [Abstract] [Full Text]

				A. E. Mautes, M. R Weinzierl, F. Donovan, and L. J Noble Vascular Events After Spinal Cord Injury: Contribution to Secondary Pathogenesis Physical Therapy, July 1, 2000; 80(7): 673 - 687. [Abstract] [Full Text] [PDF]

				C S SETHI, T A BAILEY, P J LUTHERT, and N H V CHONG Matrix metalloproteinase biology applied to vitreoretinal disorders Br. J. Ophthalmol., June 1, 2000; 84(6): 654 - 666. [Full Text]

				J. Fang, Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, G. Jackson, J. Harper, G. Tamvakopoulos, and M. A. Moses Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model PNAS, April 11, 2000; 97(8): 3884 - 3889. [Abstract] [Full Text] [PDF]

				N. Di Girolamo, P. McCluskey, A. Lloyd, M. T. Coroneo, and D. Wakefield Expression of MMPs and TIMPs in Human Pterygia and Cultured Pterygium Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 671 - 679. [Abstract] [Full Text]

				L Yan, M. Moses, S Huang, and D. Ingber Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells J. Cell Sci., January 11, 2000; 113(22): 3979 - 3987. [Abstract] [PDF]

				K. Liu, J. I. Olofsson, P. Wahlberg, and T. Ny Distinct Expression of Gelatinase A [Matrix Metalloproteinase (MMP)-2], Collagenase-3 (MMP-13), Membrane Type MMP 1 (MMP-14), and Tissue Inhibitor of MMPs Type 1 Mediated by Physiological Signals During Formation and Regression of the Rat Corpus Luteum Endocrinology, November 1, 1999; 140(11): 5330 - 5338. [Abstract] [Full Text]

				J. M. Park, R. M. Adam, C. A. Peters, P. D. Guthrie, Z. Sun, M. Klagsbrun, and M. R. Freeman AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells Am J Physiol Cell Physiol, August 1, 1999; 277(2): C294 - C301. [Abstract] [Full Text] [PDF]

				L. Yao, C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 Blood, March 1, 1999; 93(5): 1612 - 1621. [Abstract] [Full Text] [PDF]

				B. Kraling, D. Wiederschain, T Boehm, M Rehn, J. Mulliken, and M. Moses The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro J. Cell Sci., January 5, 1999; 112(10): 1599 - 1609. [Abstract] [PDF]

				M. Papetti and I. M. Herman Mechanisms of normal and tumor-derived angiogenesis Am J Physiol Cell Physiol, May 1, 2002; 282(5): C947 - C970. [Abstract] [Full Text] [PDF]

				M. L. Lindsey, J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell, et al. Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction Circulation, February 12, 2002; 105(6): 753 - 758. [Abstract] [Full Text] [PDF]